NCT06952816View on ClinicalTrials.gov

Validation Study of the EMILY AI Device in Acute and Chronic Respiratory Failure

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 23, 2025

Primary Completion Date

June 30, 2025

Study Completion Date

December 30, 2026

Conditions
Chronic Respiratory FailureAcute Respiratory Failure
Interventions
DEVICE

Emily.AI

EMILY.AI is composed of an O2 regulating valve together with an intelligent system, EDGE computing, which allows the automation in the regulation of O2 and its customization.

Trial Locations (2)

Unknown

RECRUITING

Hospital Universitario Fundación Jiménez Díaz, Madrid

RECRUITING

Hospital Universitario Fundación Jiménez Díaz, Madrid

All Listed Sponsors
collaborator

Hospital Universitario Fundación Jiménez Díaz

OTHER

collaborator

Hospital Clinic of Barcelona

OTHER

lead

Aether Tech S.L.

INDUSTRY